365betÓéÀÖ

Significance of National Pharmacovigilance Programme

The National Pharmacovigilance Programme is an initiative by the Government of India established in 2008 to monitor the safety of various drugs, including Ayurveda, Siddha, and Unani medicines. Designed to align with WHO guidelines, the program aims to enhance drug safety and encourage the reporting of adverse drug reactions. Although it has faced challenges, such as the lack of support leading to its defunct status, its overarching goal is to protect patient health through structured monitoring of drug effects.

Synonyms: Pharmacovigilance initiative, Pharmacovigilance system

The below excerpts are indicatory and do represent direct quotations or translations. It is your responsibility to fact check each reference.

The concept of National Pharmacovigilance Programme in scientific sources

Science Books

The National Pharmacovigilance Programme is an initiative by the Indian government aimed at monitoring drug safety and encouraging adverse reaction reporting, thereby enhancing the safety of medicines in India's healthcare system.

Significance in Scientific journals, articles, etc.:

From: World Journal of Pharmaceutical Research

(1) A government initiative in India aimed at ensuring drug safety and protecting patient health through structured monitoring of adverse drug effects.[1] (2) A program initiated by the CDSCO in India, designed to monitor drug safety following WHO guidelines.[2] (3) A program initiated in India to enhance the safety of Ayurvedic drugs in response to growing global concerns regarding drug safety.[3] (4) A program introduced by the Government of India that focuses on monitoring and improving the safety of medicines within the country's healthcare system.[4] (5) The National Pharmacovigilance Programme is an initiative by the Indian government to monitor the safety of drugs and to encourage reporting of adverse drug reactions.[5]

From: Journal of Ayurveda and Integrative Medicine

(1) An initiative established by the Government of India in 2008 to monitor the safety of Ayurveda, Siddha, and Unani drugs, which has since become defunct due to lack of support.[6]

This section includes scientific research in the field of healthcare, often involving traditional medicine systems such as Ayurveda, Unani, Siddha and Holistic health. It includes papers from scientific journals classified as either original, clinical or experimental research, review articles or case reports.